Inflammatory skin diseases linked to chronic kidney disease: Study

The authors undertook two complementary analyses; a prevalent case-control study and a cohort study using routinely collected primary care data [UK Clinical Practice Research Datalink (CPRD)] and matched individuals with CKD3-5 in CPRD with up to five individuals without CKD for general practitioner practice, age and sex.

The prevalence of CKD3-5 among individuals with and without each inflammatory skin disease were compared. Individuals in CPRD with diabetes mellitus in a cohort analysis to compare the incidence of CKD3-5 among people with and without atopic eczema and psoriasis were included.

The following findings were highlighted-

a. The study included 56 602 cases with CKD3-5 and 268 305 controls.

b. Cases were more likely than controls to have a history of atopic eczema [odds ratio (OR) 1·14, 99% confidence interval (CI) 1·11-1·17], psoriasis (OR 1·13, 99% CI 1·08-1·19) or hidradenitis suppurativa (OR 1·49, 99% CI 1·19-1·85), but were slightly less likely to have been diagnosed with rosacea (OR 0·92, 99% CI 0·87-0·97), after adjusting for age, sex, practice (matching factors), index of multiple deprivation, diabetes, smoking, harmful alcohol use and obesity.

c. Results remained similar after adjusting for hypertension and cardiovascular disease.

d. In the cohort with diabetes (N = 335 827), there was no evidence that CKD3-5 incidence was associated with atopic eczema or psoriasis.

Therefore, the authors concluded that "atopic eczema, psoriasis and hidradenitis suppurativa are weakly associated with CKD3-5."

However, future research is needed to elucidate potential mechanisms and the clinical significance of our findings, they further added.